<DOC>
	<DOCNO>NCT02792023</DOCNO>
	<brief_summary>Prospective study test whether immunochemical fecal occult blood test ( FIT ) colorectal cancer ( CRC ) help prioritize patient iron deficiency anemia colonoscopy .</brief_summary>
	<brief_title>Usefulness Fecal Immunochemical Test Iron Deficiency Anemia ( IDAFIT )</brief_title>
	<detailed_description>This multicenter ( two center ) , prospective study test accuracy FIT CRC detection patient severe IDA potential value prioritize colonoscopy . An appointment gastroenterologist schedule patient IDA refer upper gastrointestinal endoscopy colonoscopy . The gastroenterologist check inclusion exclusion criterion . Eligible patient sign inform consent carry follow procedure : 1 . Blood analysis rule celiac disease ( anti-transglutaminase IgA antibody IgA ) . 2 . A quantitative fecal immunological test ( FIT : OC-Sensor Â® ) provide . 3 . An appointment colonoscopy gastroscopy provide completion FIT patient . During gastroscopy , duodenal biopsy second portion duodenum duodenal bulb take rule celiac disease . Biopsies stomach also take assess helicobacter pylori infection . 4 . In patient severe anemia colonoscopy upper endoscopy prioritize ( &lt; 20 day ) ( primary outcome ) . 5 . Patients colonoscopy gastroscopy without significant lesion , schedule performance capsule endoscopy . 6 . Endoscopists blind FIT result . 7. follow information collect : consumption acetylsalicylic acid , non steroidal anti inflammatory drug , oral anticoagulant , corticosteroid proton pump inhibitor ( PPI ) . In case patient receive treatment PPIs , remove 15 day completion FIT resume performance upper endoscopy . The hypothesis study one-time FIT useful tool increase efficiency colonoscopy use prioritize outpatient colonoscopy patient IDA . In order calculate sample size require study , investigator assume FIT positive 25 % case iron deficiency anemia 20 % would advance colorectal neoplasia colonoscopy whereas 10 % advanced colorectal neoplasia would find remain 75 % patient negative FIT . Considering type I error ( alpha ) 5 % , power 80 % percentage loss 15 % , 550 patient necessary include . The investigator estimate approximately 15 % patient ( n=83 ) severe anemia .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Anemia , Iron-Deficiency</mesh_term>
	<criteria>Consecutive outpatient iron deficiency anemia ( Hemoglobin &lt; 13 g/dl male 12 g/dl female ) refer upper endoscopy and/or colonoscopy . To sign informed consent . &lt; 18 year Pregnancy Personal history inflammatory bowel disease Gastric / duodenal ulcer gastrointestinal neoplasia Family history hereditary CRC ( Lynch Syndrome familial adenomatous polyposis ) Rectal bleed / hematochezia Gastroscopy / colonoscopy / endoscopy capsule previous 5 year Patients candidate endoscopic study low performance status Previous abdominal surgery Refusal participate .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Colorectal cancer</keyword>
	<keyword>Immunochemical occult blood test</keyword>
</DOC>